Companies · Other Health Care

ConsejoSano, Inc.

NORTH HOLLYWOOD · Other Health Care

Diligence memoA one-page analyst read on ConsejoSano, Inc. — recommendation, valuation, rhythm, risks.
$18.1M
Total raised · real
2
Rounds
17.1×
Latest step-up
Top 18%
Sector rank · raised
Series B
Latest stage · inferred · Fri Nov 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

ConsejoSano, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.90× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
  • Within the normal band (90% of peer median) for its niche.
Dormant
  • Last raise 5.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

ConsejoSano, Inc. is one of 5377 Other Health Care companies tracked from NORTH HOLLYWOOD. By capital raised it ranks in the upper tier (ahead of 83% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
14
Investors (latest)
2017
Year incorporated
2020-11-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2017-01-30 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2017Series B · 2020-11-20 Raised $17M (real) Modeled valuation $336M (est)$17M$336MSeries B2020+$17MCumulative $18M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$1.0M · 2017
Series B$17.1M · 2020no Seed / Series A on file

Stages are modeled from round size (public records carry no series label). No record for: Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$335.7M
Base estimate est.
$40.1M
Conservative case
$1.2B
Upside case
$94.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $30.8M · 2017-01-302017Series B · modeled $335.7M · 2020-11-202020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
5.6 yr
Elapsed time used
5.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
46 mo
Avg between rounds
$4.7M/yr
Capital velocity
9.4 yr
On record since
2017
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.4× above median
This company$18.1M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.0× of median
This company$17.1M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 15× above median
This company$335.7M
Sector median$22.1M

Raised more than 83% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #47 of 78.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $757.1M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)National Spine & Pain Centers Holdings, LLC · Series B Raised $32.0M · modeled $708.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $621.4M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)ConsejoSano, Inc. (this company) Raised $18.1M · modeled $335.7M (est)ConsejoSano, Inc.
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.36×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$757.1M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLCSeries B$32.0M$708.9M1.89×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.86×
Lotus Parent, Inc.Series B$31.2M$690.4M1.84×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$621.4M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
ConsejoSano, Inc. this companySeries B$18.1M$335.7M0.90×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$1.0M2017-01-30$5.6M$30.8M90%
Series B$17.1M2020-11-20$94.7M$335.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$1.0M2017-01-30
    • First recorded raise — entered as Pre-Seed.
    • 7 investors on this round.
  2. Series B$17.1M2020-11-20
    • Raised again after 46 mo — slower than the ~14 mo sector norm.
    • Round 17.1× larger than the prior — scaling up.
    • 14 investors on this round.
Intelligence
2024 ~Q3
Modeled next raise · ~46mo cadence
$51.2M
Modeled next size est.range $33.3M$81.9M
17.1×
Last step-up
$4.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
LEE SHAPIRO9 other2017-01
Robert Garber7 other2020-11
Christine Aylward3 other2020-11
Michael Rudolph2 other2017-01
Molly Coye2 other2020-11
Abner Mason1 other2017-01
Derek Abruzzese2017-01
Vikram D. Bakhru2020-11
Registry & provenance

ConsejoSano, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1699132
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
HomeThrive, Inc.Other Health CareSeries B$35.3M$131.9Mnetwork2 shared operators · same sector · same stage
Trainer Rx, Inc.Other Health CareSeries B$47.0M$405.5Mnetwork1 shared operator · same sector · same stage
Perfect IP, LLCOther Health CareSeries B$18.0M$398.9Msame sector · same stage
MOTACANN Holdings, LLCOther Health CareSeries B$18.0M$398.8Msame sector · same stage
Springtide Child Development, Inc.Other Health CareSeries B$18.1M$364.3Msame sector · same stage
Fresenius Medical Care Fort Wayne, LLCOther Health CareSeries B$18.2M$402.6Msame sector · same stage
Health Strategies Group, Inc.Other Health CareSeries B$17.9M$396.3Msame sector · same stage
Olympus Topco, Inc.Other Health CareSeries B$18.3M$404.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Flebo Inc.Other Health CareSeries A$42.5M86%
Glooko, Inc.Other Health CareSeries D+$1.2B86%
Sebacia, Inc.Other Health CareSeries B$221.5M86%
Mitesco, Inc.Other Health CareSeries A$395K86%
Jutiso, Inc.Other Health CareSeries A$25.2M85%
VeMiDoc, Inc.Other Health CarePre-Seed$8.9M85%
Sonendo, Inc.Other Health CareSeries C$33.0M85%
Seguridad, Inc.Other Health CarePre-Seed$2.9M85%
Frequently asked
How much funding has ConsejoSano, Inc. raised?
ConsejoSano, Inc. has raised approximately $18.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is ConsejoSano, Inc.'s estimated valuation?
Provath's modeled valuation for ConsejoSano, Inc. is approximately $335.7M (modeled range $40.1M–$1.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is ConsejoSano, Inc. at?
ConsejoSano, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Nov 20.
What does ConsejoSano, Inc. do and where is it based?
ConsejoSano, Inc. operates in the Other Health Care sector, based in NORTH HOLLYWOOD.
Explore related

See where ConsejoSano, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at ConsejoSano, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.